Brahmer J - Search Results

1

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ. Chen L, et al. Among authors: brahmer j. Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5. Int J Radiat Oncol Biol Phys. 2018. PMID: 29485071

2

Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.

Lin TL, Brahmer JR. Lin TL, et al. Curr Oncol Rep. 2004 Jul;6(4):251-8. doi: 10.1007/s11912-004-0032-3. Curr Oncol Rep. 2004. PMID: 15161575 Review.

3

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, Mason D, Baylin SB, Herman JG, Yung RC, Brahmer J, Rudin CM, Ettinger DS, Yang SC. Brock MV, et al. Among authors: brahmer j. J Thorac Cardiovasc Surg. 2005 Jan;129(1):64-72. doi: 10.1016/j.jtcvs.2004.08.022. J Thorac Cardiovasc Surg. 2005. PMID: 15632826 Free article.

4

Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.

Juergens RA, Brahmer JR. Juergens RA, et al. Curr Oncol Rep. 2005 Jul;7(4):248-54. doi: 10.1007/s11912-005-0046-5. Curr Oncol Rep. 2005. PMID: 15946582 Review.

5

Adjuvant treatment in non-small cell lung cancer: Where are we now?

Juergens RA, Brahmer JR. Juergens RA, et al. J Natl Compr Canc Netw. 2006 Jul;4(6):595-600. doi: 10.6004/jnccn.2006.0049. J Natl Compr Canc Netw. 2006. PMID: 16813727 Review.

6

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

Juergens R, Brahmer J, Ettinger D. Juergens R, et al. Among authors: brahmer j. Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937106 Clinical Trial.

7

Second-line Therapy for advanced non-small-cell lung cancer.

Hann CL, Brahmer JR. Hann CL, et al. Curr Oncol Rep. 2006 Jul;8(4):243-7. doi: 10.1007/s11912-006-0027-3. Curr Oncol Rep. 2006. PMID: 17254522 Review.

8

Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.

Brahmer JR, Ettinger DS. Brahmer JR, et al. Respirology. 2007 May;12(3):320-5. doi: 10.1111/j.1440-1843.2007.01081.x. Respirology. 2007. PMID: 17539833 Review.

9

Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how?

Juergens R, Brahmer J. Juergens R, et al. Among authors: brahmer j. Curr Oncol Rep. 2007 Jul;9(4):255-64. doi: 10.1007/s11912-007-0031-2. Curr Oncol Rep. 2007. PMID: 17588349 Review.

10

"Who should receive epidermal growth factor receptor inhibitors for non-small cell lung cancer and when?".

Hann CL, Brahmer JR. Hann CL, et al. Curr Treat Options Oncol. 2007 Feb;8(1):28-37. doi: 10.1007/s11864-007-0024-2. Curr Treat Options Oncol. 2007. PMID: 17634830 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters